Synthesis of Boronated Uridine Derivatives for Boron Neutron Capture Therapy
The effectiveness of boron neutron capture therapy would be maximized if the capture reaction occurred in the cell nucleus.1 Thus boronated nucleic acid precursors may be ideal agents for achieving high selective boron concentrations in the nucleus of tumor cells since they should be readily taken up by rapidly proliferating malignant cells and incorporated into cellular DNA or RNA.
KeywordsBoron Neutron Capture Therapy Lithium Iodide Tetrabutylammonium Fluoride Retrosynthetic Analysis Nucleic Acid Precursor
Unable to display preview. Download preview PDF.
- 5.Y. Yamamoto, T. Seko, F.G. Rong, and H. Nemoto. Boron-10 Carriers for NCT. A New Synthetic Method via Condensation with Aldehydes having Boronic Moiety. Tetrahedron Lett. 30: 7191–7194 (1989).Google Scholar
- 6.R.F. Schinazi, and W.H. Prusoff, Synthesis of 5-(Dihydroxyboryl)-2’-deoxyuridine and Related Boron-Containing Pyrimidines. J. Org. Chem. 50: 841–847 (1985)Google Scholar
- 9.R.F. Schinazi, S. Kusuma, B.H. Laster, E. Popenoe, and R.G. Fairchild, Rational Design of Pyrimidines and Nucleosides for Neutron Capture Therapy. Boron Compounds Suitable for Neutron Capture Therapy for the Treatment of Cancer; Proceedings of the Workshop of the Radiation Research Program of NCI, Annapolis, May 3–4, 1988.Google Scholar
- 10.Y. Yamamoto, T. Seko, H. Nakamura, H. Nemoto, H. Hojo, N. Mukai, and Y. Hashimoto, Synthesis of Carboranes Containing Nucleoside Bases. Unexpectedly High Cytostatic and Cytocidal Toxicity toward Cancer Cells. J. Chem. Soc., Chem Commun. 157 (1992)Google Scholar
- 12.L. Otvos, J. Szecsi, J.Sagi, and T. Kovacs, Substrate Specificity Of DNA Polymerases. II. 5-(1-Alkynyl)dUTPs as Substrates of Klenow DNA Polymerase enzyme. Nucleic Acid Research, Symposium Series, 18: 125–129 (1987)Google Scholar
- 13.F.A. Gomez, and M.F. Hawthorne, A Simple Route to C-Monosubstituted Carborane Derivatives, J. Org. Chem. 57:1384–1390 (1992)Google Scholar